
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    Okay, I will analyze the provided marker list from the human large intestine scRNA-seq dataset to identify the cell type of this cluster.<br><br>**1. List the Key Functional Markers:**<br><br>*   **Immunoglobulin Genes (IGLL5, IGLV6-57, JCHAIN, IGLC3, IGLC2, IGHV3-7, IGKC, IGHG1, AC026369.3, IGHV3-23, IGKV4-1, IGKV1-5, IGHA1, IGLV3-1, IGLV2-11, MZB1, IGHG3, IGHV3-74, IGHM, IGKV3-20, IGHA2):** This is the most prominent group of markers. These genes encode the components of antibodies (immunoglobulins). The high and diverse expression of both heavy (IGH) and light (IGK, IGL) chain variable (V) and constant (C) regions, including different isotypes (IGHG1, IGHG3 for IgG; IGHA1, IGHA2 for IgA; IGHM for IgM), is a hallmark of cells actively producing and secreting antibodies. JCHAIN encodes the joining chain, which is required for the formation of polymeric immunoglobulins (IgA and IgM). MZB1 is involved in immunoglobulin secretion and ER function.<br>*   **DERL3, TXNDC5:** These genes are involved in the Endoplasmic Reticulum-Associated Degradation (ERAD) pathway. Cells that produce and secrete large amounts of protein, like antibodies, have highly developed ER systems and associated quality control mechanisms like ERAD. Their expression here supports high protein synthesis and secretion activity.<br>*   **CCR10:** Chemokine receptor 10. Expression of this receptor is associated with migration to mucosal tissues, including the gut, in various immune cells, notably plasma cells.<br><br>**2. List the Key Cell Type Markers:**<br><br>*   **TNFRSF17 (BCMA):** Tumor Necrosis Factor Receptor Superfamily Member 17, also known as B-cell maturation antigen (BCMA). This receptor is highly expressed on mature B cells, plasmablasts, and plasma cells and is crucial for their survival.<br>*   **MZB1:** Marginal zone B and B1 cell-specific protein 1. While initially associated with marginal zone B cells, it is highly upregulated in plasma cells and involved in immunoglobulin secretion.<br>*   **GPRC5D:** G Protein-Coupled Receptor Family C Group 5 Member D. This receptor is specifically expressed on plasma cells and is a known target in multiple myeloma.<br>*   **FCRL5:** Fc Receptor Like 5. Expressed on B cells and plasma cells, potentially involved in regulating B cell activation and antibody production.<br><br>**3. Cross-reference Known Databases:**<br><br>Cross-referencing these markers with databases like the Human Protein Atlas, PanglaoDB, and the CellMarker database confirms that the combination of high immunoglobulin gene expression, TNFRSF17, MZB1, GPRC5D, and CCR10 is highly characteristic of plasma cells. Literature on large intestine scRNA-seq consistently identifies clusters with these markers as plasma cells, particularly IgA-secreting ones, given the mucosal location.<br><br>**4. Determine the Most Probable General Cell Type:**<br><br>Based on the overwhelming expression of immunoglobulin genes, coupled with specific markers like TNFRSF17, MZB1, GPRC5D, and CCR10, and the presence of genes involved in protein secretion machinery (DERL3, TXNDC5), the most probable general cell type is **Plasma Cell**.<br><br>**5. Identify the Top 3 Most Probable Sub Cell Types:**<br><br>Considering the general cell type and the specific markers, particularly the immunoglobulin isotypes expressed:<br><br>1.  **IgA-secreting Plasma Cells:** The large intestine is a major site of IgA production. The presence of IGHA1 and IGHA2 (IgA heavy chains) among the highly expressed immunoglobulin genes strongly suggests that a significant proportion, if not the majority, of cells in this cluster are committed to producing and secreting IgA. This is the most likely specific subtype in this tissue context.<br>2.  **IgG-secreting Plasma Cells:** The presence of IGHG1 and IGHG3 (IgG heavy chains) indicates that some cells in this cluster are producing IgG. While IgA is dominant in the gut mucosa, IgG-secreting plasma cells are also present.<br>3.  **Plasma Cells (Mixed Isotype/Other Isotypes):** The cluster likely contains plasma cells secreting different isotypes (IgA, IgG, IgM as indicated by IGHM) or a mix. While IgA is likely dominant, acknowledging the presence of other isotypes or a general plasma cell population is necessary. Plasmablasts, while related, are less likely to show such a strong secretion signature and high expression of mature plasma cell markers like GPRC5D.<br><br>Based on the markers, the most likely specific subtype is **IgA-secreting Plasma Cells**.<br><br>**6. Provide a Concise Summary of Your Analysis:**<br><br>The analysis of the provided marker list reveals a strong signature of antibody production and secretion. Key markers include a wide array of immunoglobulin heavy and light chain genes (IGH, IGL, IGK), the joining chain (JCHAIN), and proteins involved in antibody secretion (MZB1) and ER function (DERL3, TXNDC5). Furthermore, the cluster expresses canonical plasma cell markers such as TNFRSF17 (BCMA), GPRC5D, and CCR10, which is associated with mucosal homing. Given the tissue origin (large intestine, a mucosal site) and the prominent expression of IGHA1 and IGHA2, this cluster is most consistent with **Plasma Cells**, predominantly **IgA-secreting Plasma Cells**.<br><br>FINAL ANNOTATION COMPLETED
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">Plasma Cell</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>IgA-secreting Plasma Cells</li><li>IgG-secreting Plasma Cells</li><li>Plasma Cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">95</div>
                        <div class="scoring-content">
                            The annotation results demonstrate a high level of scientific accuracy and a comprehensive understanding of the markers provided. Here's a detailed analysis:<br><br>1. **Correctness of the Annotations**: <br>   - The identification of the cluster as **Plasma Cells** is well-supported by the presence of canonical plasma cell markers such as **TNFRSF17 (BCMA)**, **MZB1**, and **GPRC5D**. The inclusion of **CCR10**, which is associated with mucosal homing, further strengthens the annotation, especially given the tissue origin (human large intestine).<br>   - The sub-cell type annotation as **IgA-secreting Plasma Cells** is particularly well-justified, given the high expression of **IGHA1** and **IGHA2**, which are specific to IgA production. The mention of **IgG-secreting Plasma Cells** due to **IGHG1** and **IGHG3** expression is also accurate, though IgA is correctly emphasized as the dominant isotype in this context.<br>   - The annotation also correctly notes the presence of genes involved in protein secretion and ER function (e.g., **DERL3**, **TXNDC5**), which are characteristic of plasma cells due to their high antibody production activity.<br><br>2. **Balanced Consideration of Markers**:<br>   - The analysis does not overly rely on a single marker but instead considers a broad range of immunoglobulin genes (both heavy and light chains) and other supporting markers like **JCHAIN** and **MZB1**. This balanced approach ensures that the annotation is not skewed by any single gene.<br>   - The rank of markers is implicitly considered, as the analysis highlights the most prominent markers (e.g., immunoglobulin genes) first, which aligns with their likely higher expression levels.<br><br>3. **Comprehensive View of Cell Types**:<br>   - The annotation captures the general picture of the cell population by acknowledging the heterogeneity within the cluster (e.g., the presence of both IgA and IgG-secreting plasma cells). The inclusion of **Plasma Cells** as a broader category alongside the more specific sub-cell types ensures that the annotation is not overly narrow.<br>   - The absence of obvious misclassifications or oversights is notable. For example, the analysis correctly avoids conflating plasmablasts with mature plasma cells, given the strong secretion signature and mature plasma cell markers present.<br><br>4. **Minor Weaknesses**:<br>   - While the annotation is thorough, it could briefly mention the presence of **IGHM** (IgM heavy chain) as a minor isotype, which is noted in the marker list but not explicitly discussed in the sub-cell type analysis. This is a minor oversight but does not detract significantly from the overall quality.<br>   - The annotation could also provide a brief note on the functional implications of the identified cell types (e.g., the role of IgA in mucosal immunity), though this is more of a supplementary point.<br><br>Overall, the annotation is scientifically rigorous, well-balanced, and comprehensive, with only minor areas for improvement.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    